본문으로 건너뛰기
← 뒤로

Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management.

Ultrasonography (Seoul, Korea) 2022 Vol.41(3) p. 434-443

Lee MK, Baek JH, Chung SR, Choi YJ, Lee JH, Jung SL

📝 환자 설명용 한 줄

Although differentiated thyroid cancer has an excellent prognosis and low mortality, its recurrence rate has been reported to be very high.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Lee MK, Baek JH, et al. (2022). Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management.. Ultrasonography (Seoul, Korea), 41(3), 434-443. https://doi.org/10.14366/usg.21221
MLA Lee MK, et al.. "Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management.." Ultrasonography (Seoul, Korea), vol. 41, no. 3, 2022, pp. 434-443.
PMID 35189056
DOI 10.14366/usg.21221

Abstract

Although differentiated thyroid cancer has an excellent prognosis and low mortality, its recurrence rate has been reported to be very high. While surgery is recommended as the standard treatment for recurrent thyroid cancer, reoperation may increase the incidence of complications due to fibrosis and anatomical distortion. In patients with high surgical risk or those who refuse repeated surgery, ultrasonography-guided ablation techniques including radiofrequency ablation, ethanol ablation, and laser ablation are suggested as alternative treatments. In this manuscript, we introduce an anatomy-based management concept for radiofrequency ablation for recurrent thyroid cancer, and present a review of the relevant literature, including indications, basic techniques, clinical outcomes, and complications.

같은 제1저자의 인용 많은 논문 (5)